What is NDC 0406-7018?

0406-7018 is the product NDC for Buprenorphine HCl, Buprenorphine hydrochloride 8 mg/1 tablet, listed with the FDA by SpecGx LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

SpecGx LLC, NDC labeler code 0406. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Buprenorphine HCl?

9 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Buprenorphine HCl NDC 0406-7018 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0406-7018Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00406-7018Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0406-7018-03	0040670180300406701803	30 TABLET in 1 BOTTLE (0406-7018-03)Marketed from Jan 19, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Buprenorphine HCl
Generic name (nonproprietary): buprenorphine hcl
Active ingredients: Buprenorphine hydrochloride — 8 mg/1
Dosage form: Tablet
Route: Sublingual
Labeler: SpecGx LLCNDC labeler code 0406
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218473
Marketing start: Jan 19, 2026
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Partial Opioid Agonists (Mechanism)
Identifiers: Product ID 0406-7018_d58166b1-982f-4402-af7a-a4afbcbf2e0fSPL ID d58166b1-982f-4402-af7a-a4afbcbf2e0fSPL set ID b60d514d-a88a-4fa2-a5b0-30ac29e04973RxCUI 351264, 351265UNII 56W8MW3EN1
Pharmacologic class: Partial Opioid Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Sublingual products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400406701803 followed by a unit qualifier and the quantity

Package 00406-7018-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 5, 2026.

Indications (excerpt from the label)

Buprenorphine sublingual tablets are indicated for the treatment of opioid dependence and are preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support. Buprenorphine sublingual tablets contain buprenorphine, a partial opioid agonist, and are indicated for the treatment of opioid dependence and are preferred for induction. ( 1 ) Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0406-7018

What is NDC 0406-7018?: 0406-7018 is the product NDC for Buprenorphine HCl, Buprenorphine hydrochloride 8 mg/1 tablet, listed with the FDA by SpecGx LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Buprenorphine HCl.
What is the active ingredient?: Buprenorphine hydrochloride.
Who is the labeler?: SpecGx LLC, NDC labeler code 0406. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Buprenorphine HCl?: 9 other product NDCs are listed under this name. See all Buprenorphine HCl NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Buprenorphine HCl NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Buprenorphine HCl	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	SpecGx LLC	0406-7012	00406-7012-03
Buprenorphine HCl	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	Camber Pharmaceuticals, Inc.	31722-870	31722-0870-30
Buprenorphine HCl	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	Camber Pharmaceuticals, Inc.	31722-871	31722-0871-30
Buprenorphine HCl	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	REMEDYREPACK INC.	70518-2226	70518-2226-0070518-2226-05
Buprenorphine HCl	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	REMEDYREPACK INC.	70518-2014	70518-2014-0070518-2014-02
Buprenorphine HCl	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	Clinical Solutions Wholesale, LLC	58118-0176	58118-0176-08
Buprenorphine HCl	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	Clinical Solutions Wholesale, LLC	58118-0177	58118-0177-08
Buprenorphine HCl	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	Redpharm Drug	67296-2123	67296-2123-03
Buprenorphine HCl	Buprenorphine hydrochloride 8 mg/1	TabletSublingual	Bryant Ranch Prepack	71335-1163	71335-1163-0071335-1163-0171335-1163-02+7 more

Other NDCs under ANDA 218473

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218473
Product	Strength	Form · route	Labeler	Product NDC
Buprenorphine HCl	Buprenorphine hydrochloride 2 mg/1	TabletSublingual	SpecGx LLC	0406-7012